Large-scale testing (Phase 3)Study completedNCT01332968
What this trial is testing
Obinutuzumab (RO5072759) Plus Chemotherapy in Comparison With Rituximab Plus Chemotherapy Followed by Obinutuzumab or Rituximab Maintenance in Patients With Untreated Advanced Indolent Non-Hodgkin's Lymphoma (GALLIUM)
Who this might be right for
Non-Hodgkin's Lymphoma
Hoffmann-La Roche 1,401